Anti-Profiteering Body Put Patanjali Under Scanner

Anti-profiteering body investigating the Baba Ramdev’s Patanjali Ayurveda on the behalf of a complaint registered alleging that the Patanjali made profits with selling consumer goods like cosmetics, toothpaste, shampoo etc but not passed the GST rate cut benefits announced by the GST Council meeting in November 2017. Anti-profiteering (DG-AP) investigating the issue and scanning Patanjali records.
National Anti-profiteering Authority under GST has been set up by the Narendra Modi government to secure users’ interest and to ensure that companies pass the tax cut benefits to them.

A similar complaint was registered against FMCG firm Hindustan Unilever in January 2018 and the Directorate General of Safeguards (DGS) of the anti-profiteering body investigating the issue and took three of extension to scan company accounts. DGS mandates to finish and submit reports of investigation in three months under the anti-profiteering rules but can get extensions.

An extension has been approved as the process is time-consuming and DGS asked Hindustan Unilever Limited to submit about the prices of its entire range of products pre and post GST rate cut in November 2017. GST Council rationalized GST rates on more than 200 items on November 11, 2017, and the most of items were consumer goods.

There are some other cases as well like in April 2017 DGS sent notice to Jubilant FoodWorks to share their tax cut benefits on their restaurant services from 18% to 5% were passed to customers or not at its Dominos Pizza outlet. Brands like McDonald’s franchisees, Retail shopping outlet, Lifestyle International and a Honda Car dealer have also received notices for not passing GST benefit to the consumers.
According to the last available reports, Patanjali Ayurveda reported a 53.7% hike in its net revenue of Rs 1,193.8 crore in the year ended March 2017. In January 2018 Patanjali declared that the company is partnering with big e-commerce brands such as Amazon and Flipkart to sell Patanjali products online and hoping to double its revenue to about Rs 20,000 crore by next year.

Related Posts

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines